Nida Khan MD

Medical oncology and palliative care fellow @OSUWexMed. Passionate about #palliativecare and #oncology. @OhiostatePalMed #pallonc

[Fionnuala Crowley @FionnualaCrowle]

Care Gap: Identifying and Bridging Barriers in Primary Palliative Care | Journal of Clinical Oncology https://t.co/ZSaswmtFV6 @NidaKhanMD @VBushunow @realbowtiedoc @crisbergerot @mehndz @DarcyBurbage @anhbl9 @TischCancer @oncodaily

[ASCO PallOnc Community of Practice @PallOncCoP]

Welcome all #pallonc and #supponc folks to #hapc25. We are partnering with @AAHPM Cancer Tx SIG for a joint casual dinner on Friday February 7th at 5:30p MST at Rhein Haus. If you haven't RSVP'd, reach out via DM or [email protected], we have 2 slots remaining but may⬆️

[Oncology Brothers @OncBrothers]

2024 approvals: Summary of 14 new drugs/indications in #LungCancer by @US_FDA

1. #Tepotinib
2. #Osimertinib x2
3. #Alectinib
4. #Tarlatamab
5. #Zenocutuzumab
6. #Durvalumab x2
7. #Amivantamab x2
8. #Nivolumab
9. #Ensartinib

#lcsm #OncTwitter #MedTwitter

[Oncology Data Advisor @OncData]

This week's #FellowsFriday comes from @NidaKhanMD, Fellow at @OhioStatePalMed, from her video with @RichaThakurMD on #WorldHospiceAndPalliativeCareDay.

Watch here: https://t.co/9YXV8JAyuG

And join the Fellows Forum here to be featured on Fellows Friday! https://t.co/hJBenJUbE4

[ASCO PallOnc Community of Practice @PallOncCoP]

Grateful to everyone who works in the palliative care space- ensuring patients receive holistic and goal concordant care at all stages of the care continuum.

[Eric K. Singhi, MD @lungoncdoc]

Slide updated ✅

@OncBrothers @OncoAlert #lcsm

[Oncology Data Advisor @OncData]

Have you thought about pursuing #PalliativeCare as part of your training? Here's the perfect intro for you! For #WorldHospiceAndPalliativeCareDay, @RichaThakurMD and @NidaKhanMD discuss their unique perspectives of working in palliative care.

Watch here! https://t.co/9YXV8JAyuG

[Dr Joseph McCollom DO @realbowtiedoc]

The #pallonc study that rocked #ESMO24 in @NEJM

Ph 2 trial of ponsegromab antiGDF-15 in 185 pts:
⬆️weight gain ⚖️
⬆️appetite 😋
⬆️physical activity 🏃
⬇️ #cachexia

#supponc @PallOncCoP @OncoAlert🚨 @MDRoeland @DrR_DUNNE
🔗: https://t.co/TgoYU5D2ne

[Ramy Sedhom, MD, FASCO @ramsedhom]

As always, super thoughts & writing by @BrueraEduardo

"With clear and consistent evidence of improved clinical outcomes, quality metrics, and financial outcomes with palliative care and additional evidence to support accessible and scalable interventions, what more will it take for executives, insurers, and regulators to finally support palliative care programs?"

https://t.co/sYqjpCRm6j

[Nida Khan MD @NidaKhanMD]

Incredibly well written piece. Thank you for sharing.

[Ramy Sedhom, MD, FASCO @ramsedhom]

What Do You Say When She Is No Longer Living With Cancer? | Journal of Clinical Oncology https://t.co/RmQqGAD0VT

Never easy. Cure sometimes, comfort always.

“How do you do what you do?” People ask me this all of the time at dinner parties or school pick-up. There is no party-ready answer. It is no different than trying to explain the pathophysiology of multisystem organ failure to a layperson; trying to explain how oncologists willingly care for people who die is just too complicated. But, sometimes, a student or a fellow is candid and courageous enough to ask me, truly seeking an answer—how do you tell a patient that she is dying?”

[Fionnuala Crowley @FionnualaCrowle]

Early morning hike pre Day 2 #ASCOQLTY24 with pallonc pals @anhbl9 and @NidaKhanMD

[Ryan Huey, MD, MS @ryanhuey]

Dr. Luke Peppone presents Olanzapine vs Prochlorperazine for refractory chemo-induced nausea. Both had effect over placebo, OR of 3.2 for olanzapine for a "clinically meaningful response." Olanzapine helped with max nausea, not avg nausea. Change in QOL important #ASCOQLTY24

[Dr Joseph McCollom DO @realbowtiedoc]

@MazieTsangMD presents our action packing future schedule for @PallOncCoP with some of the champions in the field including @CvonGunten @MDRoeland @NickOdomPhD_RN @NicoleStoutPT @DrN_CancerPCP @maryam_lustberg and many more📅Save the Date!📅 #pallonc #supponc

[Fumiko Ladd Chino, MD, FASCO @fumikochino]

Interventions to increase serious illness conversations often focus on acute moments in the care trajectory. This study suggests that ongoing, staged approaches are vital for goal-concordant care and may be better integrated into workflows.
Anne Montgomery, PhD, MSc #ASCOQLTY24

[ASCO PallOnc Community of Practice @PallOncCoP]

First oral abstract: RCT of olanzapine vs prochlorperazine for treatment of refractory CINV. Predictably, olanzapine wins out again. #ASCOQLTY24

[ASCO PallOnc Community of Practice @PallOncCoP]

Phenomenal presentation by @DrKerinAdelson. All systemic treatment was associated with higher HCU at the end of life. She called for systemic changes to reimbursement policies, better communication training and enhanced hospice services. #ASCOQLTY24

[Nida Khan MD @NidaKhanMD]

#ASCOQLTY2024 kicks off with @EthanBasch1 discussing the convergence of academic health service research with community quality care work and how far we’ve come in delivering quality cancer care. @ASCO

[Oncology Data Advisor @OncData]

The #FellowsForum is celebrating #PainAwarenessMonth with this enlightening dual #perspective discussion on pain.

Join @RichaThakurMD and @warriormegsie as they discuss all things #pain, from both the clinician and #patient perspective, here: https://t.co/ifbt5nUDiP

[Dr Joseph McCollom DO @realbowtiedoc]

Justin Kullgren @OSUCCC_James discusses lidocaine levels correlating closely with symptoms when used in in #hpm #hapc on @BenWThompson @HAPCVrtDidactic
@MartinsWelchMD
@KatrinaNickels
#pallonc #supponc

[Oncology Data Advisor @OncData]

Introducing the #FellowsForum! Register today to join our exclusive online community for #hematology/#oncology #fellows.

Learn more and register here! https://t.co/D9bxpGZBL8

@SamuelKareffMD @WaqasHaqueMD @RichaThakurMD @TanejaMD @NidaKhanMD @HemOncFellows @RahulBanerjeeMD